Bio X Cell Unveils New Brand Identity, Reinforcing Global Leadership in Functional Antibody Solutions Lebanon, NH — Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the functional antibody space with expanding, global capabilities across the pre-clinical research workflow. Since […]
Countable 10 is the first PCR platform to analyze 10 distinct fluorophores in the same reaction Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products PALO ALTO, Calif.–Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch […]
DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multiomic solutions, together with Eremid® Genomic Services, a specialty high-complexity genomics contract research organization and BioSkryb Certified Service Provider (CSP), today announced the launch of an Early Access Program for BioSkryb’s new ResolveSEQ LongRead solution. Through this program, researchers will gain access to services […]
FREDERICK, Md. and PLANO, Texas — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01. In March 2025, […]
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont. — Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 2R44HG013456-02 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.” Pharmacogenomics is expanding clinicians’ ability to deliver personalized medicine, enabling drug selection, dosage, efficacy, and safety to be tailored to each patient’s unique biological needs. […]
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to […]
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions. Under the […]
SALT LAKE CITY — Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read sequencing, today announced the addition of three Oxford Nanopore–developed research-use-only (RUO) assays to its service portfolio: a Pharmacogenomics (PgX) panel, Telomere Sequencing, and mRNA Vaccine Quality Control. Headquartered in a 20,000sqft CLIA-registered laboratory, […]
Caption: TheraPEAK 293-GT media system for suspension HEK203 cell lines. Caption: TheraPEAK AmpliCell Recombinant Interleukin Cytokines. AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland […]
Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours — Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ Sequencing Workflow – SOUTH SAN FRANCISCO, Calif. & SAN DIEGO–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
